Clinical Trial Update: Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating ranolazine for myocardial ischemia in patients with chronic total occlusions was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia
• Stable Angina

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: East Carolina University | Conditions: Myocardial Ischemia, Coronary Artery Disease | Phase 4 | Status: WITHDRAWN